SCHEMBL874152

SCHEMBL874152

CCNc1nc(-c2ccc(NC(=O)c3cc4cccnc4s3)cc2)ccc1C(=O)NCCN1CCSCC1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.37
DRD3 P35462 2/20 0.36
DRD2 P14416 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
KCNH2 Q12809 1/20 0.35
JAK2 O60674 2/20 0.34
NAMPT P43490 1/20 0.34
MAPT P10636 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
KDM5B Q9UGL1 6/20 0.31
JAK3 P52333 1/20 0.31
MOK Q9UQ07 2/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL874686 0.85 CYP3A4 (0.42) CHRNA7DRD3DRD2CYP3A4CYP2D6
SCHEMBL874082 0.83 MAPT (0.38) CHRNA7DRD3DRD2CYP3A4CYP2D6
SCHEMBL874151 0.83 CYP3A4 (0.40) CHRNA7DRD3DRD2CYP3A4CYP2D6
SCHEMBL874570 0.82 MOK (0.43) CHRNA7DRD3DRD2MAPTKDM4E
SCHEMBL874837 0.81 KMT2A (0.37) CHRNA7DRD3DRD2CYP3A4CYP2D6
SCHEMBL873657 0.81 CYP3A4 (0.41) CHRNA7DRD3DRD2CYP3A4CYP2D6
SCHEMBL875385 0.80 MAPT (0.40) CHRNA7CYP3A4CYP2D6CYP2C9KCNH2
SCHEMBL874025 0.79 NAMPT (0.41) CHRNA7DRD3DRD2CYP3A4CYP2D6
SCHEMBL874210 0.78 MAPT (0.40) CHRNA7NAMPTMAPTKDM4EHPGD
SCHEMBL874515 0.77 ATR (0.43) CHRNA7DRD3DRD2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038905-A1 THIENOPYRIDINE NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed